[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI2066349T1 - Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases - Google Patents

Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases

Info

Publication number
SI2066349T1
SI2066349T1 SI200730948T SI200730948T SI2066349T1 SI 2066349 T1 SI2066349 T1 SI 2066349T1 SI 200730948 T SI200730948 T SI 200730948T SI 200730948 T SI200730948 T SI 200730948T SI 2066349 T1 SI2066349 T1 SI 2066349T1
Authority
SI
Slovenia
Prior art keywords
transplantation
tumors
antibodies
treatment
autoimmune diseases
Prior art date
Application number
SI200730948T
Other languages
Slovenian (sl)
Inventor
Melissa Damschroder
Peter Kiener
Herren Wu
Acqua William Dall
Ronald Herbst
Anthony Coyle
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Priority claimed from EP07842083A external-priority patent/EP2066349B1/en
Publication of SI2066349T1 publication Critical patent/SI2066349T1/en

Links

SI200730948T 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases SI2066349T1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US84293506P 2006-09-08 2006-09-08
US86691706P 2006-11-22 2006-11-22
US91139707P 2007-04-12 2007-04-12
US91530907P 2007-05-01 2007-05-01
US93942907P 2007-05-22 2007-05-22
EP07842083A EP2066349B1 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases
PCT/US2007/077916 WO2008031056A2 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Publications (1)

Publication Number Publication Date
SI2066349T1 true SI2066349T1 (en) 2012-08-31

Family

ID=41104973

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730948T SI2066349T1 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases

Country Status (3)

Country Link
CN (1) CN101534859B (en)
CY (1) CY2022028I1 (en)
SI (1) SI2066349T1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3223798A1 (en) * 2015-04-06 2016-10-13 Regeneron Pharmaceuticals, Inc. Humanized t cell mediated immune responses in non-human animals
CN117024588A (en) * 2016-09-06 2023-11-10 华道(上海)生物医药有限公司 Application of anti-CD 19 antibody in preparation of leukemia treatment drugs
CN106599593B (en) * 2016-12-22 2019-03-26 贵州源熙生物研发有限公司 A kind of remodeling method of natural anti-cancer peptide
WO2019011918A1 (en) * 2017-07-10 2019-01-17 International - Drug - Development - Biotech Treatment of b cell malignancies using afucosylated pro-apoptotic anti-cd19 antibodies in combination with anti cd20 antibodies or chemotherapeutics
WO2020219743A2 (en) * 2019-04-24 2020-10-29 Viela Bio, Inc. Use of an anti-cd19 antibody to treat autoimmune disease
CN112578117B (en) * 2021-02-22 2021-05-25 信纳克(北京)生化标志物检测医学研究有限责任公司 Antibody composition and application thereof in screening post-transplantation lymphocyte proliferative diseases
CN114349863B (en) * 2022-03-21 2022-07-12 上海优替济生生物医药有限公司 anti-CD19 antibody and preparation method and application thereof
CN116516007B (en) * 2023-04-18 2024-01-19 华中科技大学同济医学院附属协和医院 Method for detecting CD19 expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648512A4 (en) * 2003-07-31 2009-01-21 Immunomedics Inc Anti-cd19 antibodies
KR101289537B1 (en) * 2005-02-15 2013-07-31 듀크 유니버시티 Anti-cd19 antibodies and uses in oncology

Also Published As

Publication number Publication date
CY2022028I2 (en) 2023-01-05
CY2022028I1 (en) 2023-01-05
CN101534859B (en) 2017-06-09
CN101534859A (en) 2009-09-16

Similar Documents

Publication Publication Date Title
EP1998799A4 (en) Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
EP2068925A4 (en) Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
EP1999148A4 (en) Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
FR22C1052I2 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
HK1223114A1 (en) Anti-factor xi monoclonal antibodies and methods of use thereof xi
EP2091975A4 (en) Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
CY2022028I1 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
EP2103628A4 (en) Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
IL188591A0 (en) Methods of treating autoimmune disease using humanized anti-cd16a antibodies
EP2021029A4 (en) Humanized fc riib-specific antibodies and methods of use thereof
EP2023955A4 (en) Administration of anti-cd3 antibodies in the treatment of autoimmune diseases
IL231169A0 (en) Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
IL196914A0 (en) Variable region sequences of il-31 monoclonal antibodies and methods of use
IL225386A0 (en) Diagnosis and treatment of cancer using anti-ereg antibody
IL200610A0 (en) Human monoclonal anti-ip-10 antibodies and uses thereof
EP2050466A4 (en) Diagnosis and treatment of cancer using anti-desmoglein-3 antibody
IL205866A (en) Human or humanized antibodies against nkg2d, method for their preparation and their use in the manufacture of medicaments
HK1163119A1 (en) Anti cxcr4 antibodies and their use for the treatment of cancer cxcr4
EP1793858A4 (en) Human monoclonal anti-ctla4 antibodies in cancer treatment
EP2216344A4 (en) Diagnosis and treatment of cancer using anti-gpr49 antibody
IL193604A0 (en) Methods of using antibodies against human il-22
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
EP1998807A4 (en) Methods for humanizing antibodies and humanized antibodies made thereby
WO2010054377A3 (en) Fully human antibodies against n-cadherin
EP2185718A4 (en) Human monoclonal antibodies and methods for producing the same